Medical information Clinical review pending

Cytogenetics

Immunohistochemistry Cytomegalovirus CMV Test

Detects Cytomegalovirus (CMV) in tumor tissue using immunohistochemistry. This test is important for cancer patients, especially those with weakened immune systems, to help guide treatment decisions.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Tumor tissue sample. Can be submitted as formalin-fixed paraffin-embedded (FFPE) block or 10% formalin-saline fixed tissue.
Results: Results are typically available within 5 to 7 days after sample receipt. Confirm with the laboratory before booking.
Preparation: Ensure the sample is properly labeled with patient details, site of biopsy, and date. Include a copy of the histopathology report and relevant clinical history. Ship the sample at room temperature.

Test priceKSh 6,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immunohistochemistry Cytomegalovirus CMV Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Cancer patients with suspected CMV infection
✓Immunocompromised individuals with unexplained symptoms
✓Patients undergoing cancer treatment
✓Evaluation of CMV in tumor microenvironment
✓Post-transplant patients with suspected CMV reactivation
✓Assessment of CMV-related complications in cancer

In plain language

What this test helps you understand

This test helps identify the presence of Cytomegalovirus (CMV) within tumor tissue. This information is crucial for oncologists and pathologists to understand the potential role of CMV in cancer progression, treatment response, and patient outcomes, particularly in immunocompromised individuals.

The Immunohistochemistry Cytomegalovirus (CMV) Test is a specialized diagnostic tool used primarily in oncology to detect the presence of Cytomegalovirus (CMV) in tumor tissues. CMV is a common virus that can cause significant complications in immunocompromised patients, especially those with cancer. This test is vital for oncologists and pathologists to understand the role of CMV in tumor biology and patient management.

This test measures the presence of CMV antigens within tumor tissue samples. By applying immunohistochemistry techniques, the test highlights areas where CMV is present, providing critical information about the virus's role in cancer progression and treatment response.

Patients undergoing cancer treatment or those with symptoms of CMV infection (like fever, fatigue, or unexplained weight loss) may benefit from this test. Individuals with weakened immune systems or recent organ transplants should also discuss this test with their doctor.

Benefits include accurate detection of CMV in tumors, guiding treatment plans, assessing risks of CMV complications, and supporting early intervention.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationEnsure the sample is properly labeled with patient details, site of biopsy, and date. Include a copy of the histopathology report and relevant clinical history. Ship the sample at room temperature.

SampleTumor tissue sample. Can be submitted as formalin-fixed paraffin-embedded (FFPE) block or 10% formalin-saline fixed tissue.

MethodologyImmunohistochemistry (IHC) using specific antibodies to detect CMV antigens in tissue sections.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test detects CMV antigens in tissue. It does not measure viral load or active replication. Results should be interpreted in conjunction with clinical findings and other laboratory tests. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

Cytomegalovirus (CMV) is a common virus that usually causes mild or no symptoms in healthy people, but can cause serious illness in those with weakened immune systems, such as cancer patients or transplant recipients.

The test checks if CMV is present within the tumor itself. This can help doctors understand if the virus is playing a role in the cancer's growth or how the patient might respond to treatment.

This test is typically recommended for cancer patients, especially those with weakened immune systems, or individuals who have had organ transplants and show signs of CMV infection.

A sample of tumor tissue is required. This is usually obtained during a biopsy or surgery. Your doctor will advise on the specific collection procedure.

A positive result indicates that CMV antigens were detected in the tumor tissue. Your doctor will interpret this result in the context of your overall health and clinical situation.

Results are generally available within 5 to 7 days, but this can vary. Please confirm the current turnaround time with the laboratory.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp